Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.
作者： C. S. Hampe , T. R. Hall , Å. Ågren , O. Rolandsson
DOI: 10.1111/J.1365-2249.2007.03334.X
关键词:
摘要: Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) prediabetic adults developing diabetes.
sci-hub.se 参考文章(30)
C Thivolet, S Ho, F Robert, F Rousset, A M Madec, S Lebecque, J Orgiazzi, Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated. Journal of Immunology. ,vol. 156, pp. 3541- 3549 ,(1996)
T. Tuomi, L. C. Groop, P. Z. Zimmet, M. J. Rowley, W. Knowles, I. R. Mackay, Antibodies to Glutamic Acid Decarboxylase Reveal Latent Autoimmune Diabetes Mellitus in Adults With a Non—Insulin-Dependent Onset of Disease Diabetes. ,vol. 42, pp. 359- 362 ,(1993) , 10.2337/DIAB.42.2.359
A. Falorni, C. E. Grubin, I. Takei, A. Shimada, A. Kasuga, T. Maruyama, Y. Ozawa, T. Kasatani, T. Saruta, L. Li, A. Lernmark, Radioimmunoassay Detects the Frequent Occurrence of Autoantibodies to the Mr 65,000 Isoform of Glutamic Acid Decarboxylase in Japanese Insulin-Dependent Diabetes Autoimmunity. ,vol. 19, pp. 113- 125 ,(1994) , 10.3109/08916939409009539
L. C. Groop, G. F. Bottazzo, D. Doniach, Islet Cell Antibodies Identify Latent Type I Diabetes in Patients Aged 35–75 Years at Diagnosis Diabetes. ,vol. 35, pp. 237- 241 ,(1986) , 10.2337/DIAB.35.2.237
P. Kulmala, J. Rahko, K. Savola, P. Vähäsalo, R. Veijola, M. Sjöroos, A. Reunanen, J. Ilonen, M. Knip, Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren Diabetologia. ,vol. 43, pp. 457- 464 ,(2000) , 10.1007/S001250051329
M. Schlosser, J. P. Banga, A. M. Madec, K. A. Binder, M. Strebelow, I. Rjasanowski, R. Wassmuth, L. K. Gilliam, D. Luo, C. S. Hampe, Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes Diabetologia. ,vol. 48, pp. 922- 930 ,(2005) , 10.1007/S00125-005-1719-1
C Hampe, A novel monoclonal antibody specific for the N-terminal end of GAD65 Journal of Neuroimmunology. ,vol. 113, pp. 63- 71 ,(2001) , 10.1016/S0165-5728(00)00423-9
A. Lernmark, Islet cell antibodies. Diabetic Medicine. ,vol. 4, pp. 285- 292 ,(1987) , 10.1111/J.1464-5491.1987.TB00881.X
L. K. GILLIAM, K. A. BINDER, J. P. BANGA, A.-M. MADEC, E. ORTQVIST, I. KOCKUM, D. LUO, C. S. HAMPE, Multiplicity of the antibody response to GAD65 in Type I diabetes. Clinical and Experimental Immunology. ,vol. 138, pp. 337- 341 ,(2004) , 10.1111/J.1365-2249.2004.02610.X
T. R. Hall, J. W. Thomas, C. J. Padoa, C. Torn, M. Landin-Olsson, E. Ortqvist, C. S. Hampe, Longitudinal epitope analysis of insulin-binding antibodies in type 1 diabetes. Clinical and Experimental Immunology. ,vol. 146, pp. 9- 14 ,(2006) , 10.1111/J.1365-2249.2006.03178.X